Kidney biopsy market expected to reach $2.86 billion by 2030 at 4.7% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Kidney Biopsy Market From 2026 To 2030?

The kidney biopsy market’s size has demonstrated strong growth in recent years. It is projected to expand from $2.26 billion in 2025 to $2.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. The historical expansion can be attributed to factors such as the increasing prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the established clinical dependence on renal biopsy for diagnosis, an increase in kidney transplant procedures, and the broadening reach of tertiary care hospitals.

The kidney biopsy market is projected to experience consistent growth in the coming years. It is anticipated to reach a valuation of $2.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period can be attributed to several factors, including the increasing prevalence of diabetes-related kidney conditions, the growing implementation of ultrasound- and CT-guided biopsy methods, a heightened need for early diagnosis of kidney disease, continuous advancements in imaging technologies, and broadened availability of specialized nephrology services. Key trends expected in this period include a rising preference for less invasive kidney biopsy approaches, increased utilization of image-guided percutaneous biopsies, a greater imperative for precise renal disease diagnosis, the extended application of biopsy procedures in monitoring organ transplants, and enhanced safety and accuracy in obtaining renal tissue samples.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Major Drivers Are Influencing The Expansion Of The Kidney Biopsy Market?

The anticipated increase in renal cancer cases is projected to drive the expansion of the kidney biopsy market going forward. Renal cancer is defined by the uncontrolled proliferation of abnormal kidney cells. This surge in renal cancer incidence is attributed to elements such as lifestyle changes, environmental toxins, and enhanced detection techniques resulting in more diagnoses. A kidney biopsy is crucial for both diagnosing and managing renal cancer by confirming the existence of cancerous cells, determining the cancer’s grade, aiding in treatment planning, monitoring the response to treatment, and offering prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Consequently, the rising incidence of renal cancer is a primary catalyst for the growth of the kidney biopsy market.

How Is The Kidney Biopsy Market Organized By Segment Classification?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Which Trends Are Shaping The Kidney Biopsy Market?

Leading companies engaged in the kidney biopsy market are innovating by developing platforms integrated with artificial intelligence (AI) to boost diagnostic accuracy, streamline procedures, and improve patient health outcomes. Artificial intelligence enhances kidney biopsy by refining image analysis, offering diagnostic assistance, aiding in treatment formulation, providing predictive insights, and advancing research into kidney diseases. For example, in March 2024, Aiosyn, a software company based in the Netherlands, introduced the NephroPath platform. The NephroPath platform utilizes computational pathology algorithms to analyze histological biomarkers present in kidney biopsies, encompassing the identification of tissue types, measurement of interstitial fibrosis, and precise counting and evaluation of glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, effectively addressing the shortcomings of traditional scoring methods and the variability of observer interpretation.

Who Are The Industry Participants Involved In The Kidney Biopsy Market?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Get The Full Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Is The Top Contributor To The Kidney Biopsy Market By Share?

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Kidney Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2026, By The Business Research Company

Kidney Cancer Diagnostics And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

Kidney Disease Market Report

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Liquid Biopsy Market Report

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795